Current Events |
TRIUMF joins Optimization of Medical Accelerators consortium |
24 July 2019 |
TRIUMF is pleased to announce that it has joined the Optimization of Medical Accelerators (OMA) consortium, a project that aims to maximize the healthcare benefits of medical accelerator-based therapies and improve healthcare outcomes. |
|
Awards & Honours |
Announcing the Results of the KEK-TRIUMF Exchange Program for Early Career Researchers |
25 June 2019 |
KEK (Japan’s High-Energy Accelerator Research Organization) and TRIUMF are pleased to announce the awardees for the 2019/2020 Exchange Program for Early Career Researchers (EPECR). |
|
Awards & Honours |
Dr. Marcello Pavan Awarded the UBC Killam Teaching Prize |
10 May 2019 |
In his eighth year of teaching, and after three nominations, Dr. Marcello Pavan has been awarded the Killam Teaching Prize for his outstanding teaching as part of the Faculty of Science at the University of British Columbia. |
|
Awards & Honours |
Dr. Graeme Luke awarded 2019 CAP/DCMMP Brockhouse Medal |
08 May 2019 |
Dr. Graeme Luke has been awarded the 2019 CAP/DCMMP Brockhouse Medal for his contributions in the field of superconductor research using muon-spin techniques and his leading role in developing these techniques at TRIUMF. |
|
Awards & Honours |
Dr. Scott Oser awarded 2019 CAP-TRIUMF Vogt Medal |
08 May 2019 |
Announced today, the 2019 CAP-TRIUMF Vogt Medal for Contributions to Subatomic Physics was awarded to Dr. Scott Oser of the University of British Columbia and TRIUMF. |
|
Current Events |
TRIUMF joins partners to celebrate Institute for Advanced Medical Isotopes groundbreaking |
25 April 2019 |
The Institute is expected to begin operations in late 2020 and will be a state-of-the-art facility for the research and production of next-generation, life-saving medical isotopes and radiopharmaceuticals |
|
Current Events |
CDRD and TRIUMF announce collaboration to revolutionize the fight against cancer with targeted alpha therapy |
02 April 2019 |
Speaking at the 11th International Symposium on Targeted Alpha Therapy (TAT 11) in Ottawa, the organizations announced today a new partnership that brings together their respective R&D, manufacturing, and commercialization strengths to develop innovative, personalized cancer treatments. |
|
Current Events |
Celebrating 40 years of nuclear medicine with TRIUMF’s Applied Technology Group |
06 March 2019 |
As we round the corner on TRIUMF’s 50th birthday, we also look back at one of its most important and enduring relationships and a team who has stewarded a critical contribution to the lab’s growth and success for over four decades. |
|
Current Events |
TRIUMF community celebrates recipients of inaugural Above & Beyond Awards |
13 February 2019 |
The laboratory’s inaugural peer recognition awards highlighted ingenuity, safety, and community-building. |
|
Awards & Honours |
TRIUMF Researcher Emeritus Vijay Verma receives prestigious Hind Rattan award |
17 January 2019 |
Verma is being recognized for his outstanding services, achievements and contributions within the fields of project management and engineering. |
|